Associations between serum levels of adiponectin and resistin and metabolic parameters in pregnant women with gestational diabetes mellitus

dc.contributor.authorBagci, H.
dc.contributor.authorMelekoglu, R.
dc.contributor.authorGursu, M. F.
dc.contributor.authorAkyol, A.
dc.contributor.authorBulmus, F. G.
dc.date.accessioned2026-08-12T17:05:06Z
dc.date.issued2018
dc.departmentFırat Üniversitesi
dc.description.abstractIntroduction: Gestational diabetes mellitus (GDM) is defined as a glucose intolerance firstly diagnosed during pregnancy. In this study, the authors aimed to investigate the association between serum adiponectin, and resistin levels with insulin resistance and metabolic parameters in patients with GDM. Material and Methods: A total of 80 patients: 40 healthy pregnant women (control group) and 40 pregnant women diagnosed with GDM (study group) were included in this study. Serum adiponectin, resistin, glucose, insulin, HbA1c levels, and lipid parameters were measured. Insulin resistance index HOMA-IR values were calculated. Results: Serum adiponectin levels were detected to be significantly lower (p < 0.001), whereas serum resistin levels were found to be significantly higher (p = 0.004) in GDM group compared with the control group. Levels of HDL-C, LDL-C, VLDL-C, and triglycerides were similar in both groups, but the total cholesterol level was significantly higher in the GDM group (p = 0.013). In the GDM group, adiponectin levels were negatively correlated with HbA1c levels (r = -0.368; p = 0.010) but were not correlated with any other parameter. A significant positive correlation was evident between resistin levels and both total cholesterol (r = 0.476, p = 0.001), and LDL-cholesterol (r = 0.293; p = 0.033). Conclusion: The results of this study demonstrated that serum resistin levels were significantly higher and serum adiponectin levels were significantly lower in pregnant women with GDM patients compared with normoglycemic pregnants. Also, it was detected that there was no correlation between serum adiponectin and resistin levels and insulin resistance in GDM patients.
dc.identifier.doi10.12891/ceog4348.2018
dc.identifier.endpage543
dc.identifier.issn0390-6663
dc.identifier.issn2709-0094
dc.identifier.issue4
dc.identifier.orcid0000-0003-3552-7315
dc.identifier.orcid0000-0001-5089-8961
dc.identifier.orcid0000-0001-7113-6691
dc.identifier.scopus2-s2.0-85052560705
dc.identifier.scopusqualityQ3
dc.identifier.startpage539
dc.identifier.urihttps://doi.org/10.12891/ceog4348.2018
dc.identifier.urihttps://hdl.handle.net/11508/48984
dc.identifier.volume45
dc.identifier.wosWOS:000444384300010
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherImr Press
dc.relation.ispartofClinical and Experimental Obstetrics & Gynecology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectAdiponectin
dc.subjectGestational diabetes mellitus
dc.subjectInsulin resistance
dc.subjectResistin
dc.titleAssociations between serum levels of adiponectin and resistin and metabolic parameters in pregnant women with gestational diabetes mellitus
dc.typeArticle

Dosyalar